Erytra
Total Payments
$102,949
Transactions
53
Doctors
29
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $256.55 | 3 | 3 |
| 2019 | $51,208 | 4 | 2 |
| 2018 | $48,405 | 17 | 12 |
| 2017 | $3,079 | 29 | 15 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $98,244 | 4 | 95.4% |
| Food and Beverage | $2,593 | 45 | 2.5% |
| Consulting Fee | $1,500 | 1 | 1.5% |
| Travel and Lodging | $612.24 | 3 | 0.6% |
Payments by Type
Research
$98,244
4 transactions
General
$4,705
49 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| In Vitro Study of Diagnostic Grifols Erytra Eflexis for ABORh Grouping, Antigen Typing, Direct Antiglobulin Tests, Red Blood Cell Antibody Detection, Identification, and Compatibility Testing | Grifols Diagnostic Solutions, Inc. | $62,504 | 0 |
| Diagnostic Grifols Erytra Eflexis Usability Study Protocol | Grifols Diagnostic Solutions, Inc. | $35,740 | 0 |
Top Doctors Receiving Payments for Erytra — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Blood Banking & Transfusion Medicine | Saint Louis, MO | $20.53 | 1 |
| , MD | Clinical Pathology/Laboratory Medicine | Friendswood, TX | $18.60 | 1 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Houston, TX | $18.60 | 1 |
| , MD PHD | Blood Banking & Transfusion Medicine | Houston, TX | $18.60 | 1 |
| , MD | Blood Banking & Transfusion Medicine | Tempe, AZ | $17.33 | 1 |
Ad
Manufacturing Companies
- Grifols Diagnostic Solutions, Inc. $100,608
- Grifols, S.A. $1,855
- Grifols Shared Services North America, Inc. $268.00
- Grifols Canada Ltd. $218.60
Product Information
- Type Device
- Total Payments $102,949
- Total Doctors 29
- Transactions 53
About Erytra
Erytra is a device associated with $102,949 in payments to 29 healthcare providers, recorded across 53 transactions in the CMS Open Payments database. The primary manufacturer is Grifols Diagnostic Solutions, Inc..
Payment data is available from 2017 to 2022. In 2022, $256.55 was paid across 3 transactions to 3 doctors.
The most common payment nature for Erytra is "Unspecified" ($98,244, 95.4% of total).
Erytra is associated with 2 research studies, including "In Vitro Study of Diagnostic Grifols Erytra Eflexis for ABORh Grouping, Antigen Typing, Direct Antiglobulin Tests, Red Blood Cell Antibody Detection, Identification, and Compatibility Testing" ($62,504).